BECN1 and neoplasm: A large number of studies have found that autophagy inhibitors target LC3, p62, beclin-1 and autophagy associated gene 5 (Atg5) in conjunction with PTT, while inhibiting the AKT/mTOR signaling pathway, significantly enhancing the autophagy activity in tumor cells (90, 91).